SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-041200
Filing Date
2024-03-29
Accepted
2024-03-29 17:00:36
Documents
14
Period of Report
2024-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2410183d1_8k.htm   iXBRL 8-K 28584
2 EXHIBIT 3.1 tm2410183d1_ex3-1.htm EX-3.1 302051
  Complete submission text file 0001104659-24-041200.txt   560206

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iova-20240326.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20240326_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20240326_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2410183d1_8k_htm.xml XML 3747
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 24804671
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)